Top Suppliers:I want be here

5033-28-3

5033-28-3 structure
5033-28-3 structure
  • Name: 4-Chloro-N-hydroxybenzenecarboximidamide
  • Chemical Name: 4-Chloro-N-hydroxybenzimidamide
  • CAS Number: 5033-28-3
  • Molecular Formula: C7H7ClN2O
  • Molecular Weight: 170.596
  • Create Date: 2018-04-14 08:00:00
  • Modify Date: 2024-01-10 00:41:32

Name 4-Chloro-N-hydroxybenzimidamide
Synonyms Benzenecarboximidamide, 4-chloro-N-hydroxy-
4-CHLOROBENZAMIDOXIME
MFCD00029674
4-Chloro-N-hydroxybenzenecarboximidamide
4-CHLORO-N'-HYDROXYBENZENECARBOXIMIDAMIDE
(Z)-4-Chloro-N'-hydroxybenzamidine
4-CHLORO-N'-HYDROXYBENZENECARBOXYMIDAMIDE
Density 1.4±0.1 g/cm3
Boiling Point 334.6±44.0 °C at 760 mmHg
Melting Point 129ºC
Molecular Formula C7H7ClN2O
Molecular Weight 170.596
Flash Point 156.2±28.4 °C
Exact Mass 170.024689
PSA 58.61000
LogP 1.91
Vapour Pressure 0.0±0.8 mmHg at 25°C
Index of Refraction 1.600
Name: 4-Chloro-N -hydroxybenzenecarboximidamide 95+% Material Safety Data Sheet
Synonym: 4-Chlorobenzamide oxim
CAS: 5033-28-3
Section 1 - Chemical Product MSDS Name:4-Chloro-N -hydroxybenzenecarboximidamide 95+% Material Safety Data Sheet
Synonym:4-Chlorobenzamide oxim

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
5033-28-3 4-Chloro-N'-hydroxybenzenecarboximidam 95+% unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 5033-28-3: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 129 - 132 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H7ClN2O
Molecular Weight: 171

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, bases, acids.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 5033-28-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Chloro-N'-hydroxybenzenecarboximidamide - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 5033-28-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 5033-28-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 5033-28-3 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A
Hazard Codes Xi:Irritant;
Risk Phrases R36/37/38
Safety Phrases S26-S37/39
HS Code 2925290090

~98%

5033-28-3 structure

5033-28-3

Literature: PFIZER INC. Patent: EP795328 A1, 1997 ; EP 0795328 A1 Title/Abstract Full Text Show Details Pfizer Inc. Patent: US5821245 A1, 1998 ; Title/Abstract Full Text Show Details Pfizer Inc. Patent: US6166020 A1, 2000 ; US 6166020 A

~%

5033-28-3 structure

5033-28-3

Literature: Chevron Research Company Patent: US4584317 A1, 1986 ;

~96%

5033-28-3 structure

5033-28-3

Literature: Ogurtsov, V. A.; Rakitin, O. A.; Strelenko, Yu. A.; Obruchnikova, N. V.; Khmel'nitskii, L. I. Russian Chemical Bulletin, 1993 , vol. 42, # 4 p. 706 - 708 Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1993 , # 4 p. 742 - 743

~2%

5033-28-3 structure

5033-28-3

Literature: Ogurtsov, V. A.; Rakitin, O. A.; Strelenko, Yu. A.; Obruchnikova, N. V.; Khmel'nitskii, L. I. Russian Chemical Bulletin, 1993 , vol. 42, # 4 p. 706 - 708 Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1993 , # 4 p. 742 - 743

~%

5033-28-3 structure

5033-28-3

Literature: Adib, Mehdi; Jahromi, Amin Haghighat; Tavoosi, Narjes; Mahdavi, Mohammad; Bijanzadeh, Hamid Reza Tetrahedron Letters, 2006 , vol. 47, # 17 p. 2965 - 2967

~%

5033-28-3 structure

5033-28-3

Literature: Ogurtsov, V. A.; Rakitin, O. A.; Strelenko, Yu. A.; Obruchnikova, N. V.; Khmel'nitskii, L. I. Russian Chemical Bulletin, 1993 , vol. 42, # 4 p. 706 - 708 Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1993 , # 4 p. 742 - 743

~%

5033-28-3 structure

5033-28-3

Literature: Truce,W.E.; Naik,A.R. Canadian Journal of Chemistry, 1966 , vol. 44, p. 297 - 305

~3%

5033-28-3 structure

5033-28-3

Literature: Ogurtsov, V. A.; Rakitin, O. A.; Strelenko, Yu. A.; Obruchnikova, N. V.; Khmel'nitskii, L. I. Russian Chemical Bulletin, 1993 , vol. 42, # 4 p. 706 - 708 Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1993 , # 4 p. 742 - 743
HS Code 2925290090
Summary 2925290090 other imines and their derivatives; salts thereof。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0%